| Authors: |
Azevedo RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jabbour E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jain N; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Haddad FG; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Khouri I; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Shpall EJ; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Champlin R; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Karrar O; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Maroun M; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Senapati J; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kugler E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Garris RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Ravandi F; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kantarjian H; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Short NJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA. nshort@mdanderson.org. |